Therapeutic drug monitoring of imatinib

by Pierre Wallemacq
Published 2011-01-01

Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice

by Barbara Dhooghe, Charlotte Bouckaert, Arnaud Capron, Pierre Wallemacq, Teresinha Leal, Sabrina Noel
Published 2015-07-01

Intentional acetylsalicylic acid acute intoxication and its clinical management

by Reza Soleimani, Karl Brousmiche, Julien Favresse, Vincent Haufroid, Damien Gruson, Philippe Hantson, Pierre Wallemacq
Published 2019-09-01

Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy.

by Sabrina Ritscher, Milena Hoyer, Coralie Georges, Cora Wunder, Pierre Wallemacq, Alexandre Persu, Nicholas Obermüller, Stefan W Toennes
Published 2020-01-01

Biomarkers versus traditional risk factors to predict cardiovascular events in very old adults: cross-validated prospective cohort study

by Bert Vaes, Paulien Indestege, Tinne Serneels, Eralda Hegendörfer, Rosalinde K E Poortvliet, Pierre Wallemacq, Jacobijn Gussekloo, Jan Degryse
Published 2020-06-01

Dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosis.

by François Huaux, Sabrina Noel, Barbara Dhooghe, Nadtha Panin, Sandra Lo Re, Dominique Lison, Pierre Wallemacq, Etienne Marbaix, Bob J Scholte, Patrick Lebecque, Teresinha Leal
Published 2013-01-01

Impact of rural versus urban setting on kidney markers: a cross-sectional study in South-Kivu, DRCongo

by Mannix Imani Masimango, Michel P. Hermans, Espoir Bwenge Malembaka, Pierre Wallemacq, Ernest Kiswaya Sumaili, Catherine Fillée, William D’Hoore, Cheryl A. Winkler, Sophie Limou, Michel Jadoul
Published 2021-06-01

Genetic and chemical evaluation of Trypanosoma brucei oleate desaturase as a candidate drug target.

by Andrés Alloatti, Shreedhara Gupta, Melisa Gualdrón-López, Mariana Igoillo-Esteve, Paul A Nguewa, Gladys Deumer, Pierre Wallemacq, Silvia G Altabe, Paul A M Michels, Antonio D Uttaro
Published 2010-12-01